295 related articles for article (PubMed ID: 17163407)
1. Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological diagnosis of gliomas by genotype analysis].
Nakamura M; Shimada K; Nakase H; Konishi N
Brain Nerve; 2009 Jul; 61(7):773-80. PubMed ID: 19618854
[TBL] [Abstract][Full Text] [Related]
3. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
4. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
5. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
6. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
7. Molecular Classification of Diffuse Gliomas.
Kalidindi N; Or R; Babak S; Mason W
Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
[TBL] [Abstract][Full Text] [Related]
8. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
[TBL] [Abstract][Full Text] [Related]
9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
10. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
[TBL] [Abstract][Full Text] [Related]
12. Karyometric features of low and high grade glial tumors as compared with their MRI appearance.
Scarpelli M; Montironi R; Salvolini U; Messori A; Bartels PH
Anal Quant Cytol Histol; 2004 Apr; 26(2):87-96. PubMed ID: 15131896
[TBL] [Abstract][Full Text] [Related]
13. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C
Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777
[TBL] [Abstract][Full Text] [Related]
14. Gene expression analyses of grade II gliomas and identification of rPTPbeta/zeta as a candidate oligodendroglioma marker.
Hägerstrand D; Smits A; Eriksson A; Sigurdardottir S; Olofsson T; Hartman M; Nistér M; Kalimo H; Ostman A
Neuro Oncol; 2008 Feb; 10(1):2-9. PubMed ID: 18003890
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
16. [Advances in adults' gliomas biology, imaging and treatment].
Ducray F; Dutertre G; Ricard D; Gontier E; Idbaih A; Massard C
Bull Cancer; 2010 Jan; 97(1):17-36. PubMed ID: 20028650
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Société franc¸aise de neuropathologie . Réseau de neuro-oncologie pathologique].
Figarella-Branger D; Labrousse F; Mohktari K; ;
Ann Pathol; 2012 Oct; 32(5):318-27. PubMed ID: 23141938
[TBL] [Abstract][Full Text] [Related]
18. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in tumors of the central nervous system - a review.
Scheie D; Kufaishi HHA; Broholm H; Lund EL; de Stricker K; Melchior LC; Grauslund M
APMIS; 2019 May; 127(5):265-287. PubMed ID: 30740783
[TBL] [Abstract][Full Text] [Related]
20. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]